Featured Post from Augusta University

Learn the facts – and falsehoods -- about ‘curing’ cancer

Jun 19, 2019

2 min



When it comes to cancer awareness, any news, promotion and exposure is good news. The goal of those on the frontlines of the battle against this disease is to inform the public, every message encouraging healthier living, prevention methods and hopefully, inspiring more people to support cancer research.  


Doctors can successfully treat cancer. However, there is no cure.


Just this month, as the political rhetoric continues ramping up for the 2020 election, former Vice President Joe Biden used cancer as a platform.


"A lot of you understand what loss is and when loss occurs, you know that people come up to you and tell you 'I understand' if you lose a husband, a wife, a son, a daughter, a family member," he said. "That's why I've worked so hard in my career to make sure that — I promise you if I'm elected president, you're going to see the single most important thing that changes America, we're gonna cure cancer." – USA Today, June 12


For Biden, cancer is an issue that is close to him. He lost his son to brain cancer in 2015. He’s passionate and deeply invested in those who have also lost a loved one to the disease. But his messaging was not accurate.


If you are covering cancer research, prevention and the quest for the best possible outcomes for those diagnosed and being treated for the disease, the Georgia Cancer Center at Augusta University has experts who can help with your stories.


Dr. Daniel Albo is able to discuss the fact that yes, there are highly successful treatments for a variety of different cancers. But, there is no “single bullet” that will cure every kind of cancer there is. This is the mistake Biden made during his speech. For some cancer patients, it’s about working with their doctor to find ways to manage their disease during the entirety of their life, similar to high blood pressure, diabetes, etc.


To find new treatment options and therapies for all kinds of cancer, it will take investment from multiple levels of government. But money is not all that is needed. It will take basic science researchers working with clinicians to make new “bench-to-bedside” treatment discoveries. Also, public health and prevention, as well as improving access to health care, are essential to ending the burden cancer puts on patients, their family and their friends.


Dr. Albo serves as Chair in the Department of Surgery for the Medical College of Georgia, the Surgeon-in-Chief for Augusta University Health System and associate director of surgical services for the Georgia Cancer Center. He is available to speak with media – simply click on his icon to arrange an interview.



Powered by

You might also like...

Check out some other posts from Augusta University

Can a Mother's ZIP Code Shape a Baby's Future? featured image

2 min

Can a Mother's ZIP Code Shape a Baby's Future?

Where an expectant mother lives might reveal important clues about her baby's health before birth. According to a recent Augusta University Jagwire article, researchers at the Medical College of Georgia have found that mapping birth outcomes by ZIP code can help identify communities where mothers and newborns face greater health risks, providing valuable information for healthcare providers and public health officials. The two-part study out of the Department of Anesthesiology and Perioperative Medicine at the Medical College of Georgia at Augusta University, led by Mary Arthur, MD, explored the relationship between neighborhood characteristics and neonatal outcomes. By combining geographic mapping with maternal and infant health data, the researchers identified areas with higher rates of adverse birth outcomes and examined how factors such as access to prenatal care and other social determinants of health might contribute to those disparities. The findings suggest that geographic data can become a valuable tool for improving maternal and infant health. By identifying communities at greater risk, healthcare systems and policymakers can better target prenatal education, outreach programs and healthcare resources to support expectant mothers before complications arise. For journalists covering maternal health, healthcare disparities and public policy, Arthur offers valuable insight into how community-level data can help guide interventions that improve pregnancy outcomes and give more babies a healthier start in life. "The maps make it very easy to visualize those ZIP codes that link to poor neonatal outcomes. They're also helpful for planning strategic interventions to help the people who live in those particular areas in terms of making sure there are outreach programs for mothers in those areas to have access to prenatal care." Mary Arthur, MD To learn more about this important research and connect with Mary Arthur, contact AU's External Communications Team mediarelations@augusta.edu to arrange an interview today.

Can One Gene Change the Future of Heart Disease? featured image

2 min

Can One Gene Change the Future of Heart Disease?

Heart disease remains the world's leading cause of death, but researchers are continuing to uncover the genetic mechanisms that drive it. According to a recent Augusta University Jagwire article highlighting new research, scientists are investigating how a little-studied gene might influence the development of cardiovascular disease and whether it could become a future target for treatment. At the center of the research is Kunzhe Dong, PhD, an investigator at Augusta University's Immunology Center of Georgia, who is examining the role of the SH3BGRL2 gene in cardiovascular cells. While the gene has previously been associated with cancer biology, early findings suggest it might also play an important role in regulating how blood vessels respond to stress and injury. Understanding that relationship could reveal new biological pathways involved in heart disease and identify novel opportunities for precision medicine. The research aims to determine how changes in gene expression affect the function of cardiovascular cells and contribute to disease progression. By better understanding these molecular mechanisms, scientists hope to identify new therapeutic targets and improve the ability to prevent or treat cardiovascular disease before irreversible damage occurs. The work also reflects a broader shift toward precision medicine, where treatments are tailored to the underlying biology of each patient rather than relying solely on traditional risk factors. "This gene is well known in one field, but now we're seeing it's also important in cardiovascular cells." Kunzhe Dong, PhD To learn more about this research and connect with Kunzhe Dong, contact AU's External Communications Team mediarelations@augusta.edu to arrange an interview today.

Heart Disease's Hidden Immune Players Come Into Focus featured image

2 min

Heart Disease's Hidden Immune Players Come Into Focus

Heart disease has long been linked to familiar risk factors such as high cholesterol, high blood pressure and lifestyle choices. But according to a recent Augusta University Jagwire article highlighting research published in Nature Reviews Cardiology, the immune system might also play a critical role in determining how cardiovascular disease develops and progresses. The review, led by Ishita Tandon, PhD, Hossam Abdelsamed, PhD, and Alaa M. Khalifa, PhD, examines the emerging role of CD8+ T cells, specialized immune cells best known for fighting infections, in atherosclerosis, the chronic inflammatory disease responsible for most heart attacks and strokes. By synthesizing the latest evidence, the researchers show how different populations of these immune cells can either fuel inflammation or help regulate it, revealing new opportunities to better understand, diagnose and eventually treat cardiovascular disease. The review also identifies important gaps in current knowledge and outlines promising directions for future research. As scientists continue to better understand how these immune cells behave within arterial plaques, their discoveries could lead to more precise diagnostic tools and a new generation of immune-targeted therapies for cardiovascular disease. Together, the researchers' work offers journalists valuable insight into one of the fastest-evolving areas of cardiovascular research, where immunology and heart health are converging to reshape how cardiovascular disease is understood and treated. "This study highlights the major role of CD8+ T cells in atherosclerosis and their potential impact on cardiovascular diseases."  Hossam Abdelsamed, PhD To learn more about this amazing research and connect with Ishita Tandon, Hossam Abdelsamed or Alaa M. Khalifa, contact AU's External Communications Team mediarelations@augusta.edu to arrange an interview today.

View all posts
Powered by